ALDX - Wall Street Estimates - Aldeyra Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 5.11

-19.4 %

$ 304 M

Market Cap

-6.81

P/E

Price Target Average

108.74%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

80.95%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Aldeyra Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for ALDX of $10.7 , with forecasts ranging from a low of $10 to a high of $12 .

ALDX Lowest Price Target Wall Street Target

10 USD 95.69%

ALDX Average Price Target Wall Street Target

10.7 USD 108.74%

ALDX Highest Price Target Wall Street Target

12 USD 134.83%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free